Madrigal Pharmaceuticals Inc (MDGL) — Cash Flow-to-Debt Ratio
Madrigal Pharmaceuticals Inc (MDGL) has a Cash Flow-to-Debt Ratio of -0.20x as of December 2025, meaning its operating cash flow of $-133.46 Million could theoretically repay 0% of its total liabilities ($656.90 Million) in one year. Check Madrigal Pharmaceuticals Inc (MDGL) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Madrigal Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Madrigal Pharmaceuticals Inc across 23 annual periods. Also explore how large is Madrigal Pharmaceuticals Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Madrigal Pharmaceuticals Inc (2003–2025)
Year-by-year debt coverage analysis for Madrigal Pharmaceuticals Inc. For market capitalisation and broader financial context, see Madrigal Pharmaceuticals Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.29x | $-189.55 Million | $656.90 Million | ▲ +81.8% |
| 2024 | -1.58x | $-455.57 Million | $287.86 Million | ▼ -14.8% |
| 2023 | -1.38x | $-324.23 Million | $235.21 Million | ▼ -1.3% |
| 2022 | -1.36x | $-224.86 Million | $165.18 Million | ▲ +42.8% |
| 2021 | -2.38x | $-183.92 Million | $77.22 Million | ▲ +28.9% |
| 2020 | -3.35x | $-157.56 Million | $47.02 Million | ▼ -105.2% |
| 2019 | -1.63x | $-41.62 Million | $25.49 Million | ▲ +45.9% |
| 2018 | -3.02x | $-25.51 Million | $8.44 Million | ▼ -36.1% |
| 2017 | -2.22x | $-22.32 Million | $10.05 Million | ▲ +39.5% |
| 2016 | -3.67x | $-17.61 Million | $4.80 Million | ▲ +8.7% |
| 2015 | -4.02x | $-71.44 Million | $17.79 Million | ▼ -80.9% |
| 2014 | -2.22x | $-78.92 Million | $35.54 Million | ▼ -32.3% |
| 2013 | -1.68x | $-77.41 Million | $46.11 Million | ▲ +13.3% |
| 2012 | -1.94x | $-54.13 Million | $27.95 Million | ▼ -12.8% |
| 2011 | -1.72x | $-47.30 Million | $27.55 Million | ▼ -37.5% |
| 2010 | -1.25x | $-38.20 Million | $30.59 Million | ▼ -11.8% |
| 2009 | -1.12x | $-26.81 Million | $24.00 Million | ▼ -359.5% |
| 2008 | -0.24x | $-37.94 Million | $156.04 Million | ▼ -187.3% |
| 2007 | 0.28x | $27.22 Million | $97.75 Million | ▲ +129.7% |
| 2006 | -0.94x | $-52.98 Million | $56.54 Million | ▲ +71.6% |
| 2005 | -3.30x | $-61.88 Million | $18.73 Million | ▼ -37.5% |
| 2004 | -2.40x | $-33.80 Million | $14.06 Million | ▲ +64.4% |
| 2003 | -6.75x | $-23.61 Million | $3.50 Million | — |